Flow Cytometry Market to Reach $11.34B by 2033, Growing at 7.5% CAGR | Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter, Agilent Technologies, Sony Biotechnology

The Flow Cytometry Market was valued at US$ 5.45 billion in 2023, grew to US$ 5.83 billion in 2024, and is projected to reach US$ 11.34 billion by 2033, expanding at a CAGR of 7.5% during the forecast period 2025-2033.

The Flow Cytometry Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/flow-cytometry-market?sg

Mergers & acquisitions 2025

✅ Waters Corporation announced acquisition of Becton Dickinson's (BD) Biosciences & Diagnostic Solutions business (reverse-Morris-trust style deal), ~US$17.5B - a major consolidation move that brings flow cytometry capabilities into Waters' portfolio and reshapes competitive dynamics (announcement July 2025).

✅ BD's life-sciences/business divestment process (ongoing 2025) - earlier in 2025 BD had been reported in talks and exploring divestment/spin options for its life-sciences unit, which spurred acquisition interest from Thermo Fisher, Danaher, Waters and others. (Context for the Waters deal above and market re-alignment.)

Product launches & instrument news 2025

✅ BD - BD FACSDiscoverTM A8 Cell Analyzer (launch announced May 13, 2025). Marketed as combining spectral flow capabilities with real-time cell imaging and new workflow software (BD FACSChorusTM). Featured at CYTO 2025.

✅ Beckman Coulter Life Sciences - CytoFLEX mosaic Spectral Detection Module (industry-first modular spectral detection module; March 18, 2025). Enables certain CytoFLEX models to gain spectral acquisition by adding a modular detection unit.

✅ Cytek Biosciences - Cytek AuroraTM Evo Flow Cytometer (announced May 29, 2025). Next-generation full-spectrum flow system building on Cytek's FSPTM spectral tech.

✅ Thermo Fisher Scientific - new Spectral Flow Cytometer (announced May 29, 2025) - Thermo Fisher introduced a spectral cytometer offering improved throughput/versatility; shown/demonstrated around CYTO 2025 events.

✅ Sony Biotechnology - FP7000 Spectral Cell Sorter (presence/ pushes at CYTO 2025) - Sony promoted new spectral sorter technology at CYTO 2025 (product demos / commercial presence during the show).

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/flow-cytometry-market?sg

Flow Cytometry Market Drivers:

➠ Rising Prevalence of Chronic and Infectious Diseases

Growing cases of cancer, HIV, and other immune-related disorders increase the demand for rapid and precise diagnostic techniques, positioning flow cytometry as a vital tool.

➠ Technological Advancements

Innovations such as spectral flow cytometry, automated sample preparation, and integration with artificial intelligence enhance accuracy, throughput, and usability, making these systems more attractive across laboratories.

➠ Expanding Applications in Clinical Diagnostics

Beyond research, flow cytometry is increasingly used in disease monitoring, minimal residual disease detection, hematology, and transplantation medicine.

➠ Growth in Biopharmaceutical and Vaccine Development

Rising global investments in cell-based research, biologics, and vaccine development boost demand for flow cytometry in preclinical and clinical studies.

➠ Personalized Medicine and Immunotherapy

With the growing trend toward individualized treatment approaches, flow cytometry is essential in immune profiling, biomarker discovery, and monitoring of therapeutic responses.

Flow Cytometry Market Geographical Share:

➠ North America

North America dominates the global landscape due to advanced healthcare infrastructure, strong presence of biotechnology and pharmaceutical companies, and rising adoption of high-throughput instruments in clinical diagnostics and drug discovery. Increased funding for cancer and immunology research, along with supportive regulatory approvals, further fuels regional growth.

➠ Europe

Europe holds a substantial market share, supported by well-established academic research institutes, government-funded health programs, and rising prevalence of chronic diseases. The region benefits from widespread adoption of flow cytometry in translational research, infectious disease monitoring, and vaccine development.

➠ Asia-Pacific

Asia-Pacific is emerging as the fastest-growing market, driven by rapid improvements in healthcare infrastructure, rising healthcare expenditure, and increasing awareness of advanced diagnostic technologies. Countries like China, India, and Japan are investing heavily in life sciences research, which accelerates the adoption of flow cytometry in both clinical and academic settings.

➠ Latin America and Middle East & Africa

These regions are experiencing steady adoption, supported by expanding hospital networks, partnerships with global biotech firms, and gradual integration of modern diagnostic platforms. While the market share is relatively smaller compared to developed regions, rising investments in healthcare modernization are expected to create long-term opportunities.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?sg

Strategic Players Driving the Flow Cytometry Market: Thermo Fisher Scientific, Merck KGaA (MilliporeSigma), Sysmex Corporation, Bio-Rad Laboratories, Beckman Coulter, Agilent Technologies, Sony Biotechnology, Luminex Corporation, Biocompare.

Research Methodology:

The global Flow Cytometry Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Flow Cytometry Market:

By Product Type (Instruments, Reagents/Kits)

By Application (Immunology, Oncology, Hematology, Infectious Diseases, Stem Cell Research, Drug Discovery & Development)

By End User (Hospitals & Clinics, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs))

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Flow Cytometry Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Flow Cytometry Market Research Industry:

➠ Who leads the Flow Cytometry industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Flow Cytometry market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Flow Cytometry market growth?

➠ What are the dominant sales and distribution strategies in the Flow Cytometry industry?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.